CRY News and Press, CryoLife Inc. From 12/23/19

ATLANTA , Dec. 23, 2019 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY) , a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received authorization from the U.S. Food and Drug Administration (FDA) pursuant to an Investigational New Drug ...

CryoLife (NYSE: CRY ) has entered into an agreement with Misonix (NASDAQ: MSON ) whereby latter will have exclusive US commercialization rights for CryoLife's NeoPatch product to treat a broad range of indications outside of cardiac and vascular surgery. More news on: CryoLife, Inc....

ATLANTA , Dec. 19, 2019 /PRNewswire/ --   CryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has entered into an agreement whereby Misonix (NASDAQ: MSON) will  have exclusive US commercializat...

AdaptHealth (NASDAQ: AHCO ) initiated with Outperform rating and $13 (30% upside) price target at SVB Leerink. More news on: AdaptHealth Corp., CryoLife, Inc., Acadia Healthcare Company, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

ATLANTA , Dec. 2, 2019 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has received CE Mark for the E-nya thoracic stent graft system for the minimally invasive repair of lesions of the descend...

ATLANTA , Dec. 2, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY),   a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark for the E-nside TAAA multibranch stent graft system for the endovascular treatment of thora...

CryoLife, Inc. (CRY) Q3 2019 Results Conference Call October 30, 2019 05:30 PM ET Company Participants Greg Chodaczek - Investor Relations Pat MacKin - Chief Executive Officer Ashley Lee - Chief Financial Officer Conference Call Participants Cecilia Furlong - Canaccord Genu...

Image source: The Motley Fool. CryoLife   (NYSE: CRY) Q3 2019 Earnings Call Oct 30, 2019 , 5:30 p.m. ET Operator Continue reading

CryoLife (NYSE: CRY ): Q3 Non-GAAP EPS of $0.06; GAAP EPS of $0.00 misses by $0.02 . More news on: CryoLife, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

ATLANTA , Oct. 30, 2019 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Total revenues were $67.9 million in the third quarter of 2019, reflecting year over year growth of 5% and a 6% increase on a non-GAAP constant currency basis, both compared to the third...